Skip to main content
An official website of the United States government

ovarian cancer peptide vaccine

A cancer vaccine comprised of synthetic peptides corresponding to naturally-occurring peptides derived from ovarian cancer cell antigens. Ovarian cancer peptide vaccine may elicit a cytotoxic T-cell response against tumor cells expressing the related ovarian cancer cell antigens.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Abbreviation:OC-PEP-VAC
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search